Thymosins

Thymosins are a family of small, typically acidic peptides derived from thymic and other tissue precursors. They were identified as components of thymic extracts with immunoregulatory activity. The term covers several related peptides that influence the development and function of T lymphocytes, particularly in the thymus, but they are not the same as conventional cytokines.

The most studied thymosins include thymosin alpha-1, a 28-amino-acid peptide derived from prothymosin alpha; and thymosin beta family, notably thymosin beta-4, a 43-amino-acid peptide implicated in actin sequestration and tissue repair. Other thymosins, including thymopoietin, participate in T cell maturation and thymic function. The peptides can be produced by proteolytic processing of larger precursor proteins and are present in various tissues beyond the thymus.

Biological roles: Thymosins modulate lymphocyte development and activity, influence cytokine production, and can alter innate immune responses. Some peptides promote T cell proliferation under certain conditions, while others regulate cytoskeletal dynamics in migrating cells.

Clinical and research status: Thymosin alpha-1 has been studied as an immunomodulator in viral infections and cancer, with regulatory approvals in some countries for specific indications. Thymosin beta-4 has been investigated for wound healing and regeneration. Overall, the clinical use of thymosins is limited and varies by jurisdiction, and much of their action remains under investigation.